title: A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
abstract: Epitopes of a foot-and-mouth disease virus (FMDV) capsid protein VP1 complex and a chimera of 6xHis-tagged cholera toxin B subunit (hCTB) were expressed in Hansenula polymorpha and used together as a mucosal vaccine. Antibody and cytokine responses to VP1-hCTB vaccine and protection against FMDV were evaluated by ELISA and a virus challenge test in mice, respectively. VP1-hCTB directly enhanced the expression of interleukin-5 (IL-5) both in serum and supernatants of cultured spleen cells. After challenging suckling mice with 10(5) FMDV (=50% lethal dosage per mouse) a greater protection was seen after intraperitoneal and intranasal vaccinations than after oral vaccination. In swine immunized with VP1-hCTB, immune responses were achieved after three administrations, and the vaccine protected swine (80%) when challenged with 10(6.5) FMDV (=50% infectious dosage per swine). These results demonstrated the possibility of using CTB as a mucosal adjuvant to elicit protective immune responses against FMDV.
authors.affiliation: Centre for Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, 13# Zhongguancun Beiyitiao, 100080, Beijing, PR China. songhouhui@yahoo.com.cn
authors.forename: Houhui
authors.initials: H
authors.lastname: Song
authors.forename: Zhiliang
authors.initials: Z
authors.lastname: Wang
authors.forename: Dongxia
authors.initials: D
authors.lastname: Zheng
authors.forename: Weihuan
authors.initials: W
authors.lastname: Fang
authors.forename: Yong
authors.initials: Y
authors.lastname: Li
authors.forename: Yueyong
authors.initials: Y
authors.lastname: Liu
authors.forename: Zhendong
authors.initials: Z
authors.lastname: Niu
authors.forename: Bingsheng
authors.initials: B
authors.lastname: Qiu
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000235:genetics; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D036022:Capsid Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D005260:Female; D005536:Foot-and-Mouth Disease / Q000276:immunology* / Q000517:prevention & control; D029544:Foot-and-Mouth Disease Virus / Q000235:genetics / Q000276:immunology*; D018928:Immunity, Mucosal; D015848:Interleukin-5 / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013552:Swine; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D036022:Capsid Proteins; D015848:Interleukin-5; D011993:Recombinant Fusion Proteins; C442501:VP1 protein, Foot-and-mouth disease virus; D014765:Viral Vaccines; D002772:Cholera Toxin